Psilocybin
Oregon Issues US’s First Psilocybin License
The article Oregon Issues US’s First Psilocybin License was originally published on Microdose.
Oregon Health Authority (OHA) has issued the state’s…
The article Oregon Issues US’s First Psilocybin License was originally published on Microdose.
Oregon Health Authority (OHA) has issued the state’s first psilocybin license as part of the nation’s first regulatory framework for psilocybin services. The manufacturer license was issued to Satori Farms.
The Oregon Psilocybin Services (OPS) is starting to award licenses to psilocybin facilitators, manufacturers, service centers, and laboratories. It began accepting applications on January 2, 2023 and expects to issue additional licenses in the coming months. See below for the full press release.
For more on Oregon’s psilocybin programs and roll-out, check Oregon’s Psilocybin Healing Centers: What You Need to Know and Psilocybin Therapy is Now Legal in Oregon — But There’s a Catch
Oregon Psilocybin Services issues state’s first licenses
PORTLAND, Ore. – Oregon Health Authority (OHA) has issued the state’s first psilocybin license as part of the nation’s first regulatory framework for psilocybin services. The manufacturer license was issued to a woman-owned business, Satori Farms PDX LLC, owned by Tori Armbrust. As the nation celebrates Women’s History Month, this woman-owned business will bring communities one step closer towards accessing psilocybin services in Oregon.
“We congratulate Tori Armbrust of Satori Farms PDX LLC for being issued the first psilocybin license in Oregon’s history and for representing women leading the way for the emerging psilocybin ecosystem,” says Oregon Psilocybin Services Section Manager Angie Allbee. “We are committed to fostering an inclusive partnership with our regulated community to ensure safe, effective and equitable psilocybin services throughout the state.”
The role of Oregon Psilocybin Services (OPS) is to license psilocybin facilitators, manufacturers, service centers and laboratories, while ensuring that those licensees and their workers comply with Oregon law. OPS began accepting applications for the four license types on January 2, 2023. OPS expects to issue additional licenses to laboratories, service centers and facilitators in the coming months.
Anyone interested in accessing psilocybin services can find service centers and facilitators once they are licensed on the OPS Licensee Directory website. The directory will contain licensee names and contact details for all licensees that have requested to have their information published. This may also provide opportunities for licensed psilocybin businesses to connect.
Oregon Psilocybin Services (OPS) has also begun publishing a Weekly Report on Applications for Licenses and Worker Permits. The new weekly report includes information about total number of applications received by type and status. OPS will update the report on a weekly basis.
OPS encourages the public to visit the OPS website for more information and to sign up for updates on the section’s work.
For the latest updates, subscribe to the Oregon Psilocybin Services distribution list at: oregon.gov/psilocybin
psilocybin therapy-
Psychedelics1 week ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Psychedelics1 week ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Law & Regulation1 week ago
Tryp Therapeutics merger with Exopharm approved by shareholders
-
Psilocybin1 week ago
Passover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Psychedelics1 week ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
-
Psilocybin1 week ago
Psilocybin and Meditation: Unlocking the Potential for Enhancing Insightfulness
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment